Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02614794
What this trial is testing

Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Seagen Inc. 612
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Early research (Phase 1)Active Not RecruitingNCT02589522
What this trial is testing

Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors

Who this might be right for
Metastatic Lung Neuroendocrine NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+4 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00040573
What this trial is testing

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

Who this might be right for
GliomaBrain Neoplasm
TransMolecular 18
Not applicableUnknownNCT06291662
What this trial is testing

Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing

Who this might be right for
SarcomaIntracranial NeoplasmPelvic Bone Neoplasm
Kathleen McGreevy 12
Early research (Phase 1)Study completedNCT01550523
What this trial is testing

Pilot Immunotherapy Trial for Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma of Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 13
Early research (Phase 1)WithdrawnNCT05720624
What this trial is testing

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Who this might be right for
Malignant Central Nervous System Neoplasm
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00042991
What this trial is testing

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Who this might be right for
Untreated Childhood Anaplastic AstrocytomaUntreated Childhood Anaplastic OligodendrogliomaUntreated Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 69
Early research (Phase 1)Active Not RecruitingNCT03152318
What this trial is testing

The Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more
Dana-Farber Cancer Institute 62
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Early research (Phase 1)Study completedNCT00610571
What this trial is testing

Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma
Katy Peters 62
Early research (Phase 1)Active Not RecruitingNCT03598244
What this trial is testing

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Who this might be right for
Recurrent Diffuse Intrinsic Pontine GliomaRecurrent Malignant GliomaRecurrent Medulloblastoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Looking for participantsNCT07374419
What this trial is testing

Atamparib in Patients With Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaSolid Tumor
Nerviano Medical Sciences (Shanghai) Ltd. 178
Early research (Phase 1)Active Not RecruitingNCT03696030
What this trial is testing

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges+2 more
City of Hope Medical Center 24
Early research (Phase 1)Study completedNCT05169944
What this trial is testing

Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors

Who this might be right for
Brain CancerMalignant Brain TumorRecurrent Brain Tumor+3 more
University of California, San Francisco 13
Testing effectiveness (Phase 2)Ended earlyNCT00003911
What this trial is testing

S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases

Who this might be right for
Melanoma (Skin)Metastatic Cancer
SWOG Cancer Research Network 2
Early research (Phase 1)Ended earlyNCT01103375
What this trial is testing

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Wake Forest University Health Sciences 5
Early research (Phase 1)Ended earlyNCT03967093
What this trial is testing

BXQ-350 in Children and Young Adults With Relapsed Solid Tumors

Who this might be right for
Neoplasms
Bexion Pharmaceuticals, Inc. 9
Large-scale testing (Phase 3)Study completedNCT00005887
What this trial is testing

Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Spectrum Pharmaceuticals, Inc
Very early researchWithdrawnNCT03179449
What this trial is testing

In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI

Who this might be right for
Childhood Brain Neoplasm
Michael Iv
Next Page